High levels of TGF-β, IDO, and PGE2, as well as hypoxic conditions strongly inhibit the ability of NK cells to upregulate cytokine production and expression of activating cell surface receptors, while decreasing expression of ligands for activating NK-cell receptors by tumor cells. This evidence concerns the gene TGFB1 and neoplasm.